0001437749-22-005029.txt : 20220302 0001437749-22-005029.hdr.sgml : 20220302 20220302164235 ACCESSION NUMBER: 0001437749-22-005029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kjems Lise Lund CENTRAL INDEX KEY: 0001884844 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 22704364 MAIL ADDRESS: STREET 1: 91 ROLLINGWOOD LN. CITY: CONCORD STATE: MA ZIP: 01742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINESVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0306 4 2022-02-28 0000922247 Cyclo Therapeutics, Inc. CYTH 0001884844 Kjems Lise Lund 91 ROLLINGWOOD LANE CONCORD MA 01742 1 Chief Medical Officer Stock Option (Right to buy) 3.26 2022-02-28 4 A 0 31141 0 A 2032-02-28 Common Stock 31141 31141 D The option vests over a four year period in equal monthly installments. /s/ Lise Lund Kjems 2022-03-02